Single infusion of zoledronate in Paget's disease of bone: a placebo-controlled, dose-ranging study

Bone. 1999 May;24(5 Suppl):81S-85S. doi: 10.1016/s8756-3282(99)00071-x.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Alkaline Phosphatase / blood
  • Biomarkers / blood
  • Biomarkers / urine
  • Bone Resorption / drug therapy
  • Bone Resorption / prevention & control
  • Creatinine / urine
  • Diphosphonates / administration & dosage*
  • Diphosphonates / adverse effects
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Hydroxyproline / urine
  • Imidazoles / administration & dosage*
  • Imidazoles / adverse effects
  • Infusions, Intravenous
  • Male
  • Osteitis Deformans / drug therapy*
  • Osteitis Deformans / enzymology
  • Zoledronic Acid

Substances

  • Biomarkers
  • Diphosphonates
  • Imidazoles
  • Zoledronic Acid
  • Creatinine
  • Alkaline Phosphatase
  • Hydroxyproline